News
BeneGear to Apply ADI’s HRV Application into Wearables
By Vincent Wang
Published: Jul 02,2015
BeneGear’s debut healthcare wearable is going to be high-volume manufacturing on August
HSINCHU, Taiwan — BeneGear Inc., a healthcare wearables startup, which applied ADI’s HRV application into its HRV wearables. Mike Lee, CEO of BeneGear, emphasized that heart rate variability (HRV) is the most crucial healthcare wearable.
Many medical journals indicated that Cardiovascular diseases (CVDs) are the number one cause of death globally. Therefore, Mike Lee devoted himself in researching and developing in HRV wearables.
Besides, Mike Lee even conducted a project entitled “Prediction of Blood Lactate Concentration by Physical Signals During Exercise” with Linkou Chang Gung Memorial Hospital to examine vital signs by its HRV wearables.
BeneGear applied ADI AD 8232 in its ECG product, and employed ADI ADPD142RG in their PPG product. Mike Lee praised ADI’s heart rate monitor front end of its highly integration, low-noise, low power consumption, etc.
Moreover, Mike Lee suggested that the company’s debut healthcare wearable will be high-volume manufacturing on August.
CTIMES loves to interact with the global technology related companies and individuals, you can deliver your products information or share industrial intelligence. Please email us to en@ctimes.com.tw
5323 viewed